Keywords: indevus, licenses, vantas, orion, europe, usa, pharmaceuticals

Indevus licenses Vantas to Orion in Europe

Article | 14 April 2008

The USA's Indevus Pharmaceuticals has granted Finnish drugmaker Orion rights to market Vantas (histrelin acetate subcutaneous implant) throughout Europe, as ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Histrelin Acetate Subcutaneous Implant

Supprelin LA

Go to drug listing